Inventor profile of:

Rango Dietrich

City:

Constance

Country:

Germany

Published Applications:

18

Last publication date:

2013-12-26

Top Assignees for applications by Rango Dietrich

The entities that hold a legal rights for patent applications filed by inventor Dietrich Rango:

Recent patent applications by Dietrich Rango

Rango Dietrich from Constance, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2013-12-26
US20130345265A1
Human necessities

Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient

#2 | 2011-10-13
US20110251244A1
Human necessities

Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidone as excipient

#3 | 2011-08-02
US10433304
-

Pharmaceutical preparation in the form of a paste comprising an acid-labile active ingredient

#4 | 2010-09-14
US9980492
-

Preparation and administration form comprising an acid-labile active compound

#5 | 2009-08-20
US20090208571A1
Human necessities

Dosage form containing pantoprazole as active ingredient

#6 | 2009-04-09
US20090093522A1
Human necessities

Freeze-dried pantoprazole preparation and pantoprazole injection

#7 | 2008-09-18
US20080226712A1
Human necessities

Oral administration form for pyridin-2-ylmethylsulfinyl-1H benzimidazoles

#8 | 2008-04-15
US10433305
-

Pharmaceutical preparation in the form of a suspension comprising an acid-labile active ingredient

#9 | 2008-04-01
US10855703
-

Freeze-dried pantoprazole preparation and pantoprazole injection

#10 | 2008-03-20
US20080069882A1
Human necessities

Preparation and administration form comprising an acid-labile active compound

#11 | 2007-05-31
US20070122474A1
Human necessities

Pharmaceutical preparation comprising an active dispersed on a matrix

#12 | 2007-02-13
US10433398
-

Pharmaceutical preparation comprising an active dispersed on a matrix

#13 | 2006-12-12
US10433397
-

Rapidly disintegrating tablet comprising an acid-labile active ingredient

#14 | 2006-11-23
US20060263426A1
Human necessities

Oral administration form for pyridin-2-ylmethylsulfinyl-1H-benzimidazoles

#15 | 2006-06-15
US20060127477A1
Human necessities

Preparation and administration form comprising an acid-labile active compound

#16 | 2006-05-09
US9762302
-

Oral administration form for pyridin-2-ylmethylsulfinyl-1H-benzimidazoles

#17 | 2005-07-21
US20050159492A1
Human necessities

Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient

#18 | 2005-04-26
US10423002
-

Administration form comprising an acid-labile active compound

InventorID:

6132414 ⎘